Alvotech (Iceland) Today
| ALVO Stock | 1,620 25.00 1.52% |
Performance0 of 100
| Odds Of DistressLess than 37
|
Alvotech is trading at 1620.00 as of the 29th of November 2024, a 1.52 percent decrease since the beginning of the trading day. The stock's open price was 1645.0. Alvotech has about a 37 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Alvotech are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of October 2024 and ending today, the 29th of November 2024. Click here to learn more.
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Alvotech Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Alvotech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Alvotech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | IT (View all Themes) |
| Business Concentration | IT, Drug Manufacturers-Specialty & Generic, Healthcare, Computing (View all Sectors) |
Alvotech (ALVO) is traded on Iceland Exchange in Iceland and employs 784 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 481.14 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Alvotech's market, we take the total number of its shares issued and multiply it by Alvotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Alvotech operates under Healthcare sector and is part of Drug Manufacturers-Specialty & Generic industry. The entity has 248.65 M outstanding shares.
Check Alvotech Probability Of Bankruptcy
Ownership AllocationAlvotech holds a total of 248.65 Million outstanding shares. Alvotech shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 77.32 percent of Alvotech outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Alvotech Ownership Details
Alvotech Risk Profiles
Although Alvotech's alpha and beta are two of the key measurements used to evaluate Alvotech's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.26 | |||
| Semi Deviation | 1.41 | |||
| Standard Deviation | 1.66 | |||
| Variance | 2.77 |
Alvotech Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Alvotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Top Crypto Exchanges Now
Top Crypto ExchangesSearch and analyze digital assets across top global cryptocurrency exchanges |
| All Next | Launch Module |
Alvotech Corporate Management
Elected by the shareholders, the Alvotech's board of directors comprises two types of representatives: Alvotech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Alvotech. The board's role is to monitor Alvotech's management team and ensure that shareholders' interests are well served. Alvotech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Alvotech's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Tanya Zharov | Deputy Officer | Profile | |
| Ming Li | Chief Officer | Profile | |
| Mark Levick | Chief Officer | Profile | |
| RoseMarie Ohlsson | Chief Officer | Profile | |
| Anil Okay | Chief Officer | Profile | |
| Sigridur Gudlaugsdottir | VP HR | Profile | |
| Sean Gaskell | Chief Officer | Profile |
Additional Information and Resources on Investing in Alvotech Stock
When determining whether Alvotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alvotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alvotech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alvotech Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alvotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Alvotech Stock refer to our How to Trade Alvotech Stock guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.